Company Biotoscana Investments S.A.
Equities
GBIO33
BRGBIOBDR008
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Claudio Coracini
CEO | Chief Executive Officer | - | 19-10-20 |
Director of Finance/CFO | - | 19-08-14 | |
Ivan French
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-14 |
Román Saglio
SAM | Sales & Marketing | 54 | 14-12-31 |
Renato de Giorgi
PRN | Corporate Officer/Principal | 55 | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert N. Lande
BRD | Director/Board Member | 61 | 19-11-24 |
Samira Sakhia
CHM | Chairman | 55 | 19-11-28 |
Gaëlle Lamotte
BRD | Director/Board Member | - | 19-11-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,622,306 | 104,688,619 ( 98.19 %) | 490,236 ( 0.4598 %) | 98.19 % |
Company contact information
Biotoscana Investments SA
WTC Montevideo Free Zone Dr Luis Bonavita, 1294
11300, Montevideo
+
http://www.grupobiotoscana.comSector
1st Jan change | Capi. | |
---|---|---|
+5.48% | 71.19B | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |